Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.2 to v3.6.3. This appears to be a small deployment/build update and does not indicate changes to the page content or data presented.
    Difference
    0.0%
    Check dated 2026-07-04T13:16:16.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a newer release or update to the document.
    Difference
    0.0%
    Check dated 2026-06-27T06:46:53.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label formatting was updated (Intervention/Treatment added, Intervention / Treatment removed), and the page revision updated to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-13T00:39:19.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now reports 201 locations for the study, down from 202, following the removal of Erlangen, Germany. This change updates the live listing to reflect the current sites where the study is conducted.
    Difference
    0.1%
    Check dated 2026-06-05T21:34:39.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    ENGOT is added as a collaborator for the study, and the associated investigator list is updated accordingly. Publication references are updated to include the Phase III DUO-E article in J Clin Oncol and the Erratum, along with a new revision version (v3.5.4).
    Difference
    0.1%
    Check dated 2026-05-15T05:27:57.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Collaborator listing updated to replace The Gynecologic Oncology Group (GOG) Foundation Inc with GOG Foundation and to include the DUO-E investigators; the plain-language summary citation for the DUO-E results was updated to the newer Future Oncol. 2026 article (with DOI 10.1080/14796694.2026.2638677), replacing the previous ahead-of-print citation.
    Difference
    0.0%
    Check dated 2026-05-08T00:27:33.000Z thumbnail image

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.